Behandlingen skall avbrytas vid symptomatisk hyperlaktatemi och metabol acidos/ laktacidos, progressiv hepatomegali eller snabbt stigande aminotransferaser. ###>Treatment with NRTIs should be discontinued if there is symptomatic hyperlactatemia and metabolic/ lactic acidosis, progressive hepatomegaly, or rapidly elevating aminotransferase levels.